Photo of Ronald E. Creamer Jr.

Ronald E. Creamer Jr.

Partner, Cravath

212-474-1010rcreamer@cravath.com

Two Manhattan West
375 Ninth Avenue
New York, NY 10001

View Firm Biography

Ron Creamer is a seasoned tax practitioner in all types of acquisitions and dispositions, particularly cross-border transactions. Creamer is noted for his calm, business-oriented approach and his ability to achieve consensus in complex negotiations. In addition to advising on the tax aspects of M&A transactions, Creamer regularly counsels clients on the execution and IRS review of tax-efficient financing techniques and capital markets strategies.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 Leading Dealmakers in America 2026 Tax
The 2025 Lawdragon 500 Leading Dealmakers in America 2025 Tax
The Inaugural Lawdragon 500 Leading Global Tax Lawyers 2025 Tax, Cross-Border Transactions, M&A
The 2024 Lawdragon 500 Leading Dealmakers in America 2024 Tax

Notable transactions include representing:

  • Kenvue in its pending $48.7 billion acquisition by Kimberly‑Clark;
  • Banco Sabadell in its defense against the €17 billion unsolicited takeover bid from BBVA;
  • UScellular’s independent directors in the $4.4 billion sale of UScellular’s wireless operations and select spectrum assets to T‑Mobile;
  • Deutsche Börse in its €3.9 billion acquisition of SimCorp and the combination of ISS and Qontigo’s index business as ISS STOXX;
  • Credit Suisse in its CHF3.475 billion merger into UBS;
  • Jefferies in the significant expansion of its Global Strategic Alliance with SMBC Group—which includes a joint venture combining their Japanese equities and ECM businesses, and an increase in SMBC’s equity ownership in Jefferies to up to 20%—and in the previous expansion that included a total commitment of up to $3.4 billion to Jefferies by SMBC;
  • Texas Capital Bank in the $3.4 billion sale of BankDirect to Truist;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • ADT in the $1.6 billion sale of its commercial business to GTCR and its $1.2 billion equity investment from State Farm;
  • Dowlais in its pending £1.16 billion combination with American Axle & Manufacturing; 
  • Convey Health Solutions in its $1.1 billion take-private acquisition by TPG Capital;
  • Lifezone Metals in its approximately $1 billion SPAC combination with GoGreen Investments;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate;
  • Ahold Delhaize in the sale of its FreshDirect business to Getir;
  • Airspan in the sale of Mimosa to Radisys;
  • entrotech in the formation of PPG Advanced Surface Technologies, a joint venture with PPG Industries;
  • Illumina in its spin-off of GRAIL and its pending acquisition of SomaLogic;
  • OMERS Private Equity in its acquisition of Integris and its acquisition of a majority stake in Knight Commercial;
  • Owl Rock in its investment in Amergin Asset Management;
  • Pacific General in its acquisition of a majority stake in Lenwich;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma; and
  • Thrivent in its acquisition of a majority stake in College Avenue.